| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $570K | -85.3% | -92.5% |
| SG&A Expense | $3.0M | -26.1% | +1.1% |
| Operating Income | -$3.6M | +54.8% | +65.9% |
| Income Tax | $0 | — | — |
| Net Income | -$3.5M | +55.4% | +66.7% |
| EPS (Basic) | -$0.79 | +61.8% | -92.7% |
| EPS (Diluted) | -$0.79 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $7.5M | -47.4% | -66.0% |
| Current Assets | $8.1M | -46.3% | -65.6% |
| Total Assets | $17.1M | -30.0% | -49.4% |
| Current Liabilities | $3.5M | -50.6% | -74.8% |
| Total Liabilities | $10.8M | -26.7% | -51.8% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$23.2M | — | — |
| Capital Expenditures | $0 | — | — |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $492K | — | — |
| Free Cash Flow | -$23.2M | — | — |
| -92.7% |
| $6.3M |
| -35.1% |
| -44.6% |